Dr. Liana H. Proffer, MD

Dr. Proffer practices at Proffer Surgical Center in Amarillo, Texas.

Dr. Proffer's NPI, 1891770046, was assigned on December 9, 2005. Dr. Proffer graduated from Joe R. & Teresa Lozano Long School of Medicine in 1996. Dr. Proffer holds Texas license K6910.

Dr. Proffer's primary practice is Proffer Surgical Center, at 1611 Wallace Blvd St 100, Amarillo, TX 79106. The practice phone is (806) 354-4900.

Dr. Proffer's primary practice is Proffer Surgical Center in Amarillo, Texas. Dr. Proffer is also affiliated with BSA Hospital. The medical group on file is Proffer Surgical Associates. Dmand AI also links Dr. Proffer to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Proffer practices, 3 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Proffer's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Proffer is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Proffer's licenses on file in 2 states: Texas and Ohio.

Dmand AI lists benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes and scalp rash among the conditions Dr. Proffer treats.

CMS data shows 2,917 Medicare services from Dr. Proffer across 24 procedure codes in 2024, for 523 Medicare patients. Medicare paid $683,606 for them. Every service was in an office.

CMS counts 523 Medicare patients who saw Dr. Proffer in 2024. The largest group is 75 to 84, with 215 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Proffer's median patient age at 74, with 37% women.

In 2024, Dr. Proffer wrote 652 Medicare Part D claims for 490 patients. 100% of them were for generic drugs. CMS names the drug for 611 of them, across 5 drugs with 11 or more claims each, at $3,970 in total drug cost. In 2023, CMS named 602 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Proffer for performance year 2024, reported as part of a group. Dr. Proffer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 58 procedures of melanoma (skin cancer) excision by Dr. Proffer, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Proffer in 2004. The most frequent topics are Skin Diseases and Skin Neoplasms. Dr. Proffer has published most often in J Cutan Pathol.

CMS Open Payments shows 95 general payments to Dr. Proffer from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Bioventus LLC paid the most, $412.

Dr. Proffer graduated from Joe R. & Teresa Lozano Long School of Medicine in 1996.

Dr. Proffer is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.